KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
14,880
-170 (-1.13%)
Last updated: Mar 25, 2025
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 157.60 billion as of April 1, 2025. Its market cap has decreased by -32.16% in one year.
Market Cap
157.60B
Enterprise Value
142.81B
Revenue
81.28B
Ranking
n/a
PE Ratio
41.52
Stock Price
14,880.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 157.60B, a decrease of -14.24%. That is a compound annual growth rate of -3.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 158.47B | -5.09% |
Dec 30, 2024 | 166.98B | -35.26% |
Dec 28, 2023 | 257.94B | 10.51% |
Dec 29, 2022 | 233.40B | -55.92% |
Dec 30, 2021 | 529.52B | 118.69% |
Dec 30, 2020 | 242.13B | 31.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 396.83T |
SK hynix | 137.33T |
LG Energy Solution | 83.30T |
Samsung Biologics | 74.66T |
Hyundai Motor Company | 44.69T |
Celltrion | 38.03T |
Kia Corporation | 37.52T |
KB Financial Group | 29.19T |